Royal Oak, Michigan Clinical Trials

A listing of Royal Oak, Michigan clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 43 clinical trials
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

absolute neutrophil count
squamous non-small cell lung cancer
stage iia lung squamous cell carcinoma ajcc v7
squamous non-small cell lung carcinoma
EGFR
Ascension Providence Hospitals - Southfield
 (5.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +358 other locations
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

tricuspid valve replacement
medical therapy
Henry Ford Hospital
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

This trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow …

stage ib lung cancer ajcc v8
atezolizumab
stage ia1 lung cancer ajcc v8
lung cancer
monoclonal antibodies
Ascension Providence Hospitals - Southfield
 (5.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +21 other locations
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

folfox regimen
celiac disease
esophageal cancer
solid tumor
absolute neutrophil count
Ascension Providence Hospitals - Southfield
 (5.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +254 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

pd-l1
erbb1
drug test
solid tumor
growth factor
Henry Ford Health System /ID# 216385
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +38 other locations
PB2452 in Ticagrelor-treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure

This is a multi-center, open-label, prospective single-arm study of reversal of the antiplatelet effects of ticagrelor with PB2452 in patients who present with uncontrolled major or life-threatening bleeding or who require urgent surgery or invasive procedure. Approximately 200 patients will be enrolled at approximately 200 centers worldwide. Patients with reported …

systolic blood pressure
stroke
coronary artery bypass graft
packed red blood cells
postoperative hemorrhage
Beaumont Hospital, Royal Oak
 (2.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma

This is a phase II open-label study investigating the efficacy, safety and pharmacokinetic(PK) properties of OKN-007 combined with temozolomide(TMZ) in patients with recurrent glioblastoma(GBM). All patients will have been previously treated with the standard-of-care treatment which includes surgical resection, radiation and chemotherapy, and in some cases treatment for recurrent disease. …

Henry Ford Health System
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which is affecting an increasing number of military personnel and young active individuals in the general population. The proposed study will investigate critical patient, disease, and surgical treatment predictors of FAI surgery outcomes.

conservative management
hip arthroscopy
arthroscopy
femoroacetabular impingement
William Beaumont Hospital
 (2.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +11 other locations
Clinical and Genetic Analysis of ROP

Retinopathy of Prematurity (ROP) is a vascular disease affecting the retinas (back of the eye) of low birth weight infants. Although it can be treated effectively if diagnosed early, it continues to be a leading cause of childhood blindness in the United States and throughout the world. The investigators feel …

pediatric
retinopathy
prematurity
blindness
vascular disease
William Beaumont Hospital
 (2.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
VENOUS: A Translational Study of Enterococcal Bacteremia

The purpose of this study is to assemble a multicenter prospective cohort of patients with enterococcal bloodstream infections (BSIs) to provide data on outcomes of patients with enterococcal BSIs for sample size calculations for future trials, as well as to characterize enterococcal isolates causing BSIs in order to comprehensively dissect …

Henry Ford Hospital and Medical Centers
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +11 other locations